Immunovaccine Announces Achievement of Milestones in Collaboration with Zoetis to Develop Veterinary Vaccines
“We are extremely pleased with the recent progress of our long-standing collaboration with
Immunovaccine Forward-Looking Statements
This press release contains forward-looking information under applicable securities law. All information that addresses activities or developments that we expect to occur in the future is forward-looking information. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. However, they should not be regarded as a representation that any of the plans will be achieved. Actual results may differ materially from those set forth in this press release due to risks affecting the Company, including access to capital, the successful completion of clinical trials and receipt of all regulatory approvals.
Immunovaccine: MEDIA Mike Beyer, Sam Brown Inc.T: (312) 961-2502 E: email@example.com INVESTOR RELATIONS Pierre Labbé, Chief Financial Officer T: (902) 492-1819 E: firstname.lastname@example.org Patti Bank, Managing Director, Westwicke PartnersO: (415) 513-1284 T: (415) 515-4572 E: email@example.com